On August 27, Accord Healthcare Inc. issued a voluntary, nationwide recall for one lot of Hydrochlorothiazide Tablets USP, a medication used to treat high blood pressure, due to a labeling mix-up.

According to a statement from the U.S. Food and Drug Administration (FDA), the recall was issued after a bottle from lot PW05264, labeled as Hydrochlorothiazide Tablets USP, 12.5 mg, was found to incorrectly contain Spironolactone Tablets USP 25 mg, a medication used to treat congestive heart failure, cirrhosis of the liver and other ailments. The FDA says that the effects of mixing up the medications depends on the individual, but can range from "limited" to "life-threatening."

Accord's Hydrochlorothiazide Tablets USP 12.5 mg can be identified by this visual guide. The FDA recommends that individuals in possession of Accord Hydrochlorothiazide tablets that do not match this description contact their pharmacy or health care provider.

Clinical Topics: Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Prevention, Statins, Acute Heart Failure, Hypertension

Keywords: ACC Advocacy, Hydrochlorothiazide, Spironolactone, United States Food and Drug Administration, Pharmaceutical Services, Hypertension, Heart Failure

< Back to Listings